Best Compounded GLP-1 Pharmacy: 7 Providers Compared (2026)

What does "compounded GLP-1" actually mean?

Compounded GLP-1 is semaglutide or tirzepatide prepared by a licensed pharmacy for a specific patient, rather than manufactured as a finished, FDA-approved product. The active molecule is identical to what's in Ozempic, Wegovy, Mounjaro or Zepbound — a compounding pharmacy is mixing the same ingredient, typically at a lower price, without the brand-name packaging or the FDA's finished-drug review.

That last part is the real distinction, and it's worth sitting with. The FDA reviews commercial drugs for potency, purity, sterility and manufacturing consistency before they reach a pharmacy shelf. A compounded version skips that specific review. It's still made by a state-licensed pharmacy under pharmacy law, and a prescriber still has to sign off — but the safety net looks different, which is why the rules about when compounding is even allowed matter as much as the price tag.

Is compounded GLP-1 legal in 2026 — or has it been banned?

It hasn't been banned. It's just no longer the free-for-all it was in 2023. Both semaglutide and tirzepatide were on the FDA's drug shortage list, which is what let compounding pharmacies produce them at scale for anyone who wanted a cheaper option. Tirzepatide came off that list at the end of 2024, and the FDA's own enforcement-discretion windows for compounders closed by March 19, 2025. Semaglutide followed: the FDA issued a formal declaratory order on February 21, 2025 finding the shortage resolved, with compounder enforcement discretion running out by April 22, 2025 for 503A pharmacies and May 22, 2025 for 503B outsourcing facilities.

What survived that shift is narrower. A 503A pharmacy can still legally compound either drug for a specific, named patient when a prescriber documents a genuine clinical reason the commercial version won't work — a documented allergy to an inactive ingredient, or a dose strength that isn't commercially sold, for example. The FDA has also said it generally won't act against a pharmacy filling four or fewer prescriptions of a compounded product per month, which is a meaningful safe harbor for smaller operations. Compounding purely because it's cheaper isn't, on its own, a qualifying clinical reason under current guidance — see the FDA's own compounder policy statement for the specifics.

• Tirzepatide 503A/503B enforcement discretion for shortage-era compounding: ended Feb 18 and March 19, 2025, respectively.
• Semaglutide 503A/503B enforcement discretion: ended April 22 and May 22, 2025, respectively.
• What remains legal: 503A compounding for a named patient with a documented, individual clinical need.
• What isn't a qualifying reason on its own: wanting a lower price than the branded drug.
• On April 30, 2026, FDA proposed excluding semaglutide, tirzepatide and liraglutide from the 503B bulk substances list entirely — the public comment period closed in late June 2026, and as of this writing no final rule has been issued. That proposal targets 503B bulk compounding, which had already wound down; it does not change the 503A pathway every provider on this page uses.

Is compounded GLP-1 safe?

Same active molecule, different oversight. The FDA doesn't review a compounded formulation's potency, sterility or consistency the way it does Wegovy or Zepbound, which means the quality of your pharmacy's compounding process matters more than it would with a brand-name drug. Some compounded formulations also add ingredients like B12 or L-carnitine that aren't in the FDA-approved brand and haven't been independently evaluated in combination with semaglutide or tirzepatide.

This isn't hypothetical. In March 2025, Washington state reportedly shut down Aequita, a compounding pharmacy that had supplied several large telehealth GLP-1 programs, over sterile-compounding violations including unlicensed staff handling medication. It's a real illustration of why the pharmacy behind your prescription — not just the telehealth brand on the label — is worth asking about. A program whose prescribing clinician actually reviews your labs and documents a specific clinical reason for compounding, rather than approving a form in under a minute, is doing the part of this that keeps you safest.

• Ask which pharmacy fills your prescription, and whether it's accredited by PCAB or licensed by its state board.
• Ask whether the formulation contains anything beyond the active molecule, and what evidence exists for combining it that way.
• A reputable program will name its pharmacy without hesitation; one that won't is a signal worth taking seriously.

If side effects — not legitimacy — are your main hesitation, the medication's known profile doesn't change because it's compounded rather than branded; see the full rundown at GLP-1 side effects.

Where to find a reliable compounded GLP-1 pharmacy

The best compounded GLP-1 pharmacy for you isn't necessarily the cheapest one — it's the one that's transparent about its pharmacy partner, publishes its dose-by-dose pricing rather than hiding behind a "starting at" number, and has a prescriber who will actually talk to you about why compounding fits your situation. Among providers that clear that bar, price is where the real differences show up, and that's true whether you're weighing semaglutide, tirzepatide, or trying to decide between them.

Compounded GLP-1 prices compared: 7 pharmacies offering both semaglutide and tirzepatide

These are the seven programs we could verify compound both molecules, with real, dated, all-in prices — not the teaser number on the landing page. A few others in this space (Ro, for instance) compound only one molecule or have pivoted mostly to brand-name product; they're covered on the molecule-specific pages linked below rather than here.

Curex — lowest starting price for either molecule

Curex publishes a flat "from $149" for semaglutide and "from $199" for tirzepatide, with no separate membership fee stacked on top — a rarer structure than it should be in this category. The consult, the medication itself and shipping are all folded into that single number, and unlimited follow-ups and dose adjustments are included.

The caveat is the word "from." Curex doesn't publish a full maintenance-dose price ladder for either drug, so the starter-dose rate you see on the homepage may not be what you pay once you titrate up. Ask for the complete dose-by-dose schedule in writing before enrolling.

• Pros — lowest verified starting price for both molecules; no membership fee; oral and injectable formats; unlimited follow-ups included.
• Cons — maintenance-dose pricing isn't publicly posted for either drug; confirm the full ladder before committing.

Mochi Health — flat medication price, separate membership

Mochi splits its billing into two lines: a flat medication fee that never rises with dose ($99/mo semaglutide, $199/mo tirzepatide), plus a $79/mo membership that covers its ABOM-certified physician network and care coordination. Add them together and the real all-in cost is $178/mo for semaglutide or $278/mo for tirzepatide — worth knowing before you're quoted the smaller number. For the full audit, see our Mochi Health review.

• Pros — flat medication fee at any dose for either molecule; obesity-medicine board-certified physicians; nationwide coverage.
• Cons — the advertised $99/$199 medication price isn't the real total; add the $79/mo membership to see what you'll actually pay.

Fridays — coaching and dietitian bundled into the price

Fridays prices itself as a program, not just a prescription. Semaglutide runs from about $150/mo on a 12-month plan up to $249/mo month-to-month; tirzepatide runs $240 to $359/mo on the same schedule. Dietitian access, group coaching and 24/7 messaging are included at every tier — no extra charge for the support layer that some other programs sell separately or skip entirely.

• Pros — cheapest annual rate on either molecule in this group with real clinical support bundled; no separate membership fee.
• Cons — the low rate requires a 12-month prepay, and Fridays' BBB profile shows a pattern of complaints about refund difficulty on those prepayments.

Eden — no membership, first-month discount

Eden keeps the structure simple: no membership fee, a flat rate at every dose level, and a discounted first month on either molecule. Expect roughly $149 to start on semaglutide, stepping up to about $249/mo ongoing; tirzepatide starts near $249 and settles around $329/mo. As with most of this category, the exact ongoing figure varies a little by source and by plan — worth confirming on the live checkout page.

• Pros — no separate membership; flat rate across dose tiers; discounted entry month on both molecules.
• Cons — ongoing rate is meaningfully higher than the first-month price; confirm the exact figure before assuming it'll hold.

Peak Wellness — cheaper the longer you commit

Peak Wellness holds a flat rate across doses for either drug, with no membership fee riding alongside it. The number that moves is the commitment length: semaglutide runs from roughly $165/mo on a longer prepay up to $249/mo standard, and tirzepatide from about $232 to $349/mo on the same structure. The lower figures you'll see in ads are the multi-month rate, not the month-to-month price — check which one your plan actually locks in.

• Pros — flat rate regardless of dose; no membership fee; meaningful discount for prepaying several months.
• Cons — the eye-catching low price requires a longer commitment; standard month-to-month is closer to the top of the range.

Henry Meds — oral or injectable, fully bundled

Henry Meds is one of the few programs offering an oral option for both molecules alongside the standard injection, which matters if needles are the thing keeping you from starting. Semaglutide runs $249/mo oral or $297/mo injection; tirzepatide runs $349/mo oral or $449/mo injection. Visits, supplies and shipping are all bundled into that single number, there's no membership fee, and you can cancel month to month. For the full picture, see our Henry Meds review.

• Pros — oral and injectable formats for both molecules; fully bundled pricing with no membership; cancel anytime.
• Cons — the highest price in this group for tirzepatide injection at $449/mo; no dedicated coaching layer like Fridays.

Willow — flat pricing in 33 states

Willow keeps a single flat number for each molecule regardless of dose: $299/mo for compounded semaglutide, $399/mo for compounded tirzepatide, with no membership fee and both injectable and oral dissolving tablet options for semaglutide. Willow also carries LegitScript certification, an independent check on whether a pharmacy or telehealth operator is complying with prescribing law — a real trust signal in a market with plenty of unvetted operators. The constraint is geography: coverage currently runs to 33 states, so confirm yours is on the list before intake.

• Pros — flat price at every dose for either molecule; LegitScript certified; oral and injectable semaglutide options.
• Cons — priced at the higher end of this group; only available in 33 states; no live video consultations.

Compounded semaglutide vs. compounded tirzepatide: which is right for you

Across every program on this page, tirzepatide costs more than semaglutide — usually $50 to $150 more a month, depending on the provider. That price gap tracks the mechanism: tirzepatide acts on both the GLP-1 and GIP receptors, while semaglutide works on GLP-1 alone, and that dual action has generally produced larger average effects in trials. It also means a real trade-off, not a strictly better option — more receptors involved can mean a different side-effect experience for some women, and semaglutide has a longer real-world track record simply because it reached the market first.

How compounded GLP-1 pricing actually works

The advertised price is rarely the whole story. Curex, Eden, Peak Wellness and Willow hold a flat rate across every dose level, so titrating up doesn't raise your bill — a genuine advantage over programs that quietly charge more at a higher dose. Henry Meds' pricing varies by format (oral vs. injection) rather than by dose. Mochi's medication fee is flat, but its separate $79/mo membership sits beside it rather than being folded in, which is easy to miss on a first look at the homepage.

Intro rates and ongoing rates are a separate thing to track. Fridays and Peak Wellness both reward a longer prepay with a meaningfully lower monthly number — sometimes 30 to 40 percent below the month-to-month rate — while Eden's first-month discount is smaller and shorter-lived. None of that is dishonest, but it means the number in the ad and the number on your sixth bill can be two different figures.

Run the cheapest and priciest options here through a full year and the range gets stark: Curex's compounded tirzepatide at roughly $199 a month comes to about $2,388 a year, while Willow's flat $399 a month for the same molecule totals close to $4,788 a year — a difference of exactly $2,400 depending only on which of these two pharmacies you pick, before you've weighed anything but the sticker price.

Red flags before you enroll with any compounding pharmacy

• The provider won't name the compounding pharmacy filling your prescription, or dodges the question.
• No online consult or intake review at all — just a checkout page and a shipment.
• A maintenance-dose price that isn't published anywhere, even after you ask directly.
• Billing every 28 days instead of monthly, which quietly charges you 13 times a year instead of 12.
• A multi-month prepay with no clear refund or cancellation policy in writing.
• A price meaningfully below everything else on this page with no explanation for how that's possible.

Compounded GLP-1 and perimenopause: does the hormonal context change anything

Weight that shows up in your forties and fifties often has more to do with hormonal shifts than a change in habits. Estrogen decline changes where fat gets stored, and insulin sensitivity commonly worsens through the perimenopause years — both of which make weight harder to manage through diet alone, compounded or brand-name GLP-1 aside. That doesn't change which molecule or pharmacy is cheapest, but it's part of why the coaching-and-dietitian bundles some of these programs sell (Fridays, most notably) can be worth more to a woman in this stage than the bare medication price suggests.

If the hormonal piece matters as much to you as the weight piece, it's a fair question to put to any provider directly: do their clinicians have specific experience with perimenopause, or is this a general weight-management script applied the same way regardless of age or hormonal stage.